Ganoderic acid A suppresses glycolytic metabolism and promotes apoptosis in A549 lung adenocarcinoma cells with concurrent ALDOA downregulation

Ganoderic acid A (GAA) is a bioactive triterpenoid with reported anticancer activity, yet its effects on tumor glycolytic metabolism remain incompletely understood. The present study investigated the effects of GAA on glycolysis and apoptosis in A549 lung adenocarcinoma (LUAD) cells and examined the potential involvement of fructose‑bisphosphate aldolase A (ALDOA). Cell viability was assessed using a Cell Counting Kit‑8 assay, apoptosis was evaluated by Annexin V/PI flow cytometry and glycolytic activity was measured using a Seahorse XF‑96 Extracellular Flux Analyzer. Western blotting, biochemical assays and public LUAD transcriptomic analyses were also performed. GAA reduced cell viability and increased apoptosis, accompanied by increased cleaved caspase‑3 levels, decreased total caspase‑3 and Bcl‑2 expression and increased Bax expression. GAA also markedly suppressed glycolytic metabolism, as indicated by reductions in extracellular acidification rate, glycolytic capacity and reserve, glucose consumption, lactate production and intracellular ATP levels. Analysis of LUAD transcriptomic datasets showed that ALDOA was upregulated in tumor tissues and was associated with poorer overall survival, higher glycolysis‑associated pathway activity and lower apoptosis‑associated pathway activity. In A549 cells, GAA decreased ALDOA protein expression and total cellular aldolase activity in a concentration‑dependent manner. Molecular docking and molecular dynamics simulations further predicted a plausible GAA‑ALDOA interaction, while cellular thermal shift assays provided cellular target‑engagement evidence supporting the potential interaction between GAA and ALDOA. However, the causal contribution of ALDOA to the metabolic and apoptotic effects of GAA remains to be established. Collectively, the present findings identified GAA as a suppressor of glycolytic metabolism in A549 cells and suggested that ALDOA‑associated metabolic regulation may represent a potential mechanism underlying its pro‑apoptotic pharmacological effects.

Authors

Institutions

Publication Details

Journal
Oncology Letters
Published
2026-11-18
DOI
https://doi.org/10.3892/ol.2026.15952
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Ganoderic acid A suppresses glycolytic metabolism and promotes apoptosis in A549 lung adenocarcinoma cells with concurrent ALDOA downregulation

Yulu Tian, Yanzhao Chen, Long Mu, Qi Zhang et al.
2 links
Oncology Letters
Cancer, Hypoxia, and Metabolism
article

Ganoderic acid A suppresses glycolytic metabolism and promotes apoptosis in A549 lung adenocarcinoma cells with concurrent ALDOA downregulation

Yulu Tian, Yanzhao Chen, Long Mu, Qi Zhang, Haowen Luo, Shuqi Ding, Jun Xiao
article en

Abstract

Ganoderic acid A (GAA) is a bioactive triterpenoid with reported anticancer activity, yet its effects on tumor glycolytic metabolism remain incompletely understood. The present study investigated the effects of GAA on glycolysis and apoptosis in A549 lung adenocarcinoma (LUAD) cells and examined the potential involvement of fructose‑bisphosphate aldolase A (ALDOA). Cell viability was assessed using a Cell Counting Kit‑8 assay, apoptosis was evaluated by Annexin V/PI flow cytometry and glycolytic activity was measured using a Seahorse XF‑96 Extracellular Flux Analyzer. Western blotting, biochemical assays and public LUAD transcriptomic analyses were also performed. GAA reduced cell viability and increased apoptosis, accompanied by increased cleaved caspase‑3 levels, decreased total caspase‑3 and Bcl‑2 expression and increased Bax expression. GAA also markedly suppressed glycolytic metabolism, as indicated by reductions in extracellular acidification rate, glycolytic capacity and reserve, glucose consumption, lactate production and intracellular ATP levels. Analysis of LUAD transcriptomic datasets showed that ALDOA was upregulated in tumor tissues and was associated with poorer overall survival, higher glycolysis‑associated pathway activity and lower apoptosis‑associated pathway activity. In A549 cells, GAA decreased ALDOA protein expression and total cellular aldolase activity in a concentration‑dependent manner. Molecular docking and molecular dynamics simulations further predicted a plausible GAA‑ALDOA interaction, while cellular thermal shift assays provided cellular target‑engagement evidence supporting the potential interaction between GAA and ALDOA. However, the causal contribution of ALDOA to the metabolic and apoptotic effects of GAA remains to be established. Collectively, the present findings identified GAA as a suppressor of glycolytic metabolism in A549 cells and suggested that ALDOA‑associated metabolic regulation may represent a potential mechanism underlying its pro‑apoptotic pharmacological effects.

Oncology LettersVol. 33(1)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), China Academy of Chinese Medical Sciences (CN)
Good health and well-being
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon